BridgeMD
New treatment option for Hirsuitism
Official title Comparison of a Face Cream Plus a Laser Procedure and Face Cream Alone in Treatment of Excessive Face Hairs in Female
ClinicalTrials.gov ID: NCT06976424
What this study is testing
What is Eflornithine Topical?
Eflornithine Topical is an investigational medicine, given as a treatment applied to the skin, being studied as a potential treatment for hirsuitism.
Also referred to as Eflornithine cream.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study compares the effects of a cream alone and a combined effect of cream and laser for the treatment of excessive facial hairs in women .
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Gender (Female) Age between 18-45 Years Women with hirsutism as mentioned in the operational definition
You likely can't join if
- Pregnant women Women with severe acne Women with immunodeficiency
The study team makes the final eligibility decision.
Where it's taking place
- Peshawar, Kpk, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Peshawar, Kpk, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.